- Home
- CRNX vs RITM Comparison
CRNX vs RITM Comparison
Compare CRNX & RITM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- RITM
- Stock Information
- Founded
- CRNX 2008
- RITM 2011
- Country
- CRNX United States
- RITM United States
- Employees
- CRNX N/A
- RITM N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- RITM Real Estate Investment Trusts
- Sector
- CRNX Health Care
- RITM Real Estate
- Exchange
- CRNX Nasdaq
- RITM Nasdaq
- Market Cap
- CRNX 5.2B
- RITM 6.2B
- IPO Year
- CRNX 2018
- RITM N/A
- Fundamental
- Price
- CRNX $32.33
- RITM $11.29
- Analyst Decision
- CRNX Strong Buy
- RITM Buy
- Analyst Count
- CRNX 12
- RITM 9
- Target Price
- CRNX $73.36
- RITM $13.00
- AVG Volume (30 Days)
- CRNX 956.8K
- RITM 4.1M
- Earning Date
- CRNX 05-08-2025
- RITM 04-29-2025
- Dividend Yield
- CRNX N/A
- RITM 8.78%
- EPS Growth
- CRNX N/A
- RITM 51.82
- EPS
- CRNX N/A
- RITM 1.67
- Revenue
- CRNX $1,039,000.00
- RITM $3,786,887,000.00
- Revenue This Year
- CRNX $394.51
- RITM N/A
- Revenue Next Year
- CRNX $699.82
- RITM $13.55
- P/E Ratio
- CRNX N/A
- RITM $6.82
- Revenue Growth
- CRNX N/A
- RITM 34.29
- 52 Week Low
- CRNX $31.84
- RITM $10.38
- 52 Week High
- CRNX $62.53
- RITM $12.20
- Technical
- Relative Strength Index (RSI)
- CRNX 46.96
- RITM 40.17
- Support Level
- CRNX $32.90
- RITM $11.58
- Resistance Level
- CRNX $36.45
- RITM $11.84
- Average True Range (ATR)
- CRNX 1.42
- RITM 0.21
- MACD
- CRNX 0.26
- RITM -0.04
- Stochastic Oscillator
- CRNX 51.49
- RITM 37.65
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
About RITM Rithm Capital Corp.
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company's mission is to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Rithm Capital's investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights) loans (including single-family rental), and consumer loans.